cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.15156/bio/sh1412940.10fu
title: SH1412940.10FU

description: UNITE provides a unified way for delimiting, identifying, communicating, and working with DNA-based Species Hypotheses (SH). All fungal ITS sequences in the international nucleotide sequence databases are clustered to approximately the species level by applying a set of dynamic distance values (<0.5 - 3.0%). All species hypotheses are given a unique, stable name in the form of a DOI, and their taxonomic and ecological annotations are verified through distributed, web-based third-party annotation efforts. SHs are connected to a taxon name and its classification as far as possible (phylum, class, order, etc.) by taking into account identifications for all sequences in the SH. An automatically or manually designated sequence is chosen to represent each such SH. These sequences are released (https://unite.ut.ee/repository.php) for use by the scientific community in, for example, local sequence similarity searches and next-generation sequencing analysis pipelines. The system and the data are updated automatically as the number of public fungal ITS sequences grows.
DOI: 10.15156/bio/sh1412941.10fu
title: SH1412941.10FU

description: UNITE provides a unified way for delimiting, identifying, communicating, and working with DNA-based Species Hypotheses (SH). All fungal ITS sequences in the international nucleotide sequence databases are clustered to approximately the species level by applying a set of dynamic distance values (<0.5 - 3.0%). All species hypotheses are given a unique, stable name in the form of a DOI, and their taxonomic and ecological annotations are verified through distributed, web-based third-party annotation efforts. SHs are connected to a taxon name and its classification as far as possible (phylum, class, order, etc.) by taking into account identifications for all sequences in the SH. An automatically or manually designated sequence is chosen to represent each such SH. These sequences are released (https://unite.ut.ee/repository.php) for use by the scientific community in, for example, local sequence similarity searches and next-generation sequencing analysis pipelines. The system and the data are updated automatically as the number of public fungal ITS sequences grows.
DOI: 10.15156/bio/sh1412942.10fu
title: SH1412942.10FU

description: UNITE provides a unified way for delimiting, identifying, communicating, and working with DNA-based Species Hypotheses (SH). All fungal ITS sequences in the international nucleotide sequence databases are clustered to approximately the species level by applying a set of dynamic distance values (<0.5 - 3.0%). All species hypotheses are given a unique, stable name in the form of a DOI, and their taxonomic and ecological annotations are verified through distributed, web-based third-party annotation efforts. SHs are connected to a taxon name and its classification as far as possible (phylum, class, order, etc.) by taking into account identifications for all sequences in the SH. An automatically or manually designated sequence is chosen to represent each such SH. These sequences are released (https://unite.ut.ee/repository.php) for use by the scientific community in, for example, local sequence similarity searches and next-generation sequencing analysis pipelines. The system and the data are updated automatically as the number of public fungal ITS sequences grows.
DOI: 10.15156/bio/sh1412943.10fu
title: SH1412943.10FU

description: UNITE provides a unified way for delimiting, identifying, communicating, and working with DNA-based Species Hypotheses (SH). All fungal ITS sequences in the international nucleotide sequence databases are clustered to approximately the species level by applying a set of dynamic distance values (<0.5 - 3.0%). All species hypotheses are given a unique, stable name in the form of a DOI, and their taxonomic and ecological annotations are verified through distributed, web-based third-party annotation efforts. SHs are connected to a taxon name and its classification as far as possible (phylum, class, order, etc.) by taking into account identifications for all sequences in the SH. An automatically or manually designated sequence is chosen to represent each such SH. These sequences are released (https://unite.ut.ee/repository.php) for use by the scientific community in, for example, local sequence similarity searches and next-generation sequencing analysis pipelines. The system and the data are updated automatically as the number of public fungal ITS sequences grows.
DOI: 10.15156/bio/sh1412945.10fu
title: SH1412945.10FU

description: UNITE provides a unified way for delimiting, identifying, communicating, and working with DNA-based Species Hypotheses (SH). All fungal ITS sequences in the international nucleotide sequence databases are clustered to approximately the species level by applying a set of dynamic distance values (<0.5 - 3.0%). All species hypotheses are given a unique, stable name in the form of a DOI, and their taxonomic and ecological annotations are verified through distributed, web-based third-party annotation efforts. SHs are connected to a taxon name and its classification as far as possible (phylum, class, order, etc.) by taking into account identifications for all sequences in the SH. An automatically or manually designated sequence is chosen to represent each such SH. These sequences are released (https://unite.ut.ee/repository.php) for use by the scientific community in, for example, local sequence similarity searches and next-generation sequencing analysis pipelines. The system and the data are updated automatically as the number of public fungal ITS sequences grows.
DOI: 10.15156/bio/sh1412949.10fu
title: SH1412949.10FU

description: UNITE provides a unified way for delimiting, identifying, communicating, and working with DNA-based Species Hypotheses (SH). All fungal ITS sequences in the international nucleotide sequence databases are clustered to approximately the species level by applying a set of dynamic distance values (<0.5 - 3.0%). All species hypotheses are given a unique, stable name in the form of a DOI, and their taxonomic and ecological annotations are verified through distributed, web-based third-party annotation efforts. SHs are connected to a taxon name and its classification as far as possible (phylum, class, order, etc.) by taking into account identifications for all sequences in the SH. An automatically or manually designated sequence is chosen to represent each such SH. These sequences are released (https://unite.ut.ee/repository.php) for use by the scientific community in, for example, local sequence similarity searches and next-generation sequencing analysis pipelines. The system and the data are updated automatically as the number of public fungal ITS sequences grows.
DOI: 10.13140/rg.2.2.11614.64328
title: Poster_Franziska_Kellner
DOI: 10.13140/rg.2.2.33425.02403
title: الكره الأرضيه
DOI: 10.13140/rg.2.2.18692.53129
title: The RAD-NNET-SSPP website-update-1
DOI: 10.13140/rg.2.2.32219.16165
title: Chaotic Grey Wolf Optimization
DOI: 10.15468/dl.wkj4f5
title: Occurrence Download

description: A dataset containing 169 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is one of (Citharexylum berlandieri)",
 "StateProvince is one of (Mexico Central, Mexico Gulf, Mexico Northeast, Mexico Northwest, Mexico Southwest, Texas)",
 "BasisOfRecord is Specimen"
 ]
}

 The dataset includes 169 records from 20 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0025493-251009101135966/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.13140/rg.2.2.27284.30082
title: Two sample problem for zero inflated data
DOI: 10.15468/dl.chxpem
title: Occurrence Download

description: A dataset containing 229814 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Continent is North America",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "Month is October",
 "OccurrenceStatus is Present",
 "TaxonKey is one of (Crocodylia, Testudines, Squamata, Amphibia, Reptilia, Serpentes)",
 "Year 2016-2025"
 ]
}

 The dataset includes 229814 records from 104 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0025450-251009101135966/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.fi86il
title: Occurrence Download

description: A dataset containing 452291560 species occurrences available in GBIF matching the query:
{
 "or" : [
 "TaxonKey is Animalia",
 "TaxonKey is Crotalus willardi Meek, 1905"
 ]
}

 The dataset includes 452291560 records from 6471 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0013398-160118175350007/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.13018/bmr19481
title: The Solution Structure of the Regulatory Domain of Tyrosine Hydroxylase
DOI: 10.13018/bmr19482
title: The Solution Structure of the Regulatory Domain of Tyrosine Hydroxylase
DOI: 10.13018/bmr19483
title: Solution structure of the WW domain of HYPB
DOI: 10.13018/bmr19484
title: NMR structure of a two-transmembrane segment TM VI-VII of NHE1
DOI: 10.13018/bmr19485
title: Chemical Shift Assignments for SVIP (small VCP/p97-interacting protein)
DOI: 10.13018/bmr19486
title: Solution NMR Structure of Zinc finger protein 423 from Homo sapiens, Northeast Structural Genomics Consortium (NESG) Target HR7298F
DOI: 10.13018/bmr19487
title: Solution structure of the PP2WW mutant (KPP2WW) of HYPB
DOI: 10.13018/bmr19488
title: Solution structure of WW domain with polyproline stretch (PP2WW) of HYPB
DOI: 10.13018/bmr19489
title: NMR SOLUTION STRUCTURE OF MSP-P56S DOMAIN/VAPB in DPC
DOI: 10.13018/bmr19490
title: Human cytosolic dNT-1 nucleotidase
DOI: 10.13018/bmr19491
title: 1H, 13C, 15N chemical shift assignments of full-length apo human Galectin-3 (2-250).
DOI: 10.13018/bmr19493
title: NMR structure of purotoxin-2 in water
DOI: 10.13018/bmr19494
title: HuR RRM3 WT
DOI: 10.13018/bmr19495
title: HN, NH, CA, CB and methyl group assignments of Filamin C two Ig-domain fragment FLNc4-5
DOI: 10.13018/bmr19496
title: HN, NH, CA, CB and methyl group assignments of Filamin A three Ig-domain fragment FLNa3-5
DOI: 10.13018/bmr19497
title: calcium-free V6 domain of villin
DOI: 10.13018/bmr19498
title: gp1.2
DOI: 10.13018/bmr19499
title: HuR RRM3 W261E mutant
DOI: 10.6084/m9.figshare.31422272
title: Supplementary Material for: Differentiating behavioural presentations of biomarker-confirmed Alzheimer’s disease from frontotemporal lobar degeneration using the Addenbrooke's Cognitive Examination-III

description: Introduction: Differentiating frontotemporal lobar degeneration (FTLD) from Alzheimer’s disease (AD), particularly when presenting with overlapping behavioural symptoms, remains clinically challenging. This study assessed the utility of Addenbrooke's Cognitive Examination-III (ACE-III)-derived ratios in distinguishing these conditions.

Methods: A retrospective cohort of 115 patients (n=52 biomarker-confirmed AD, n=63 FTLD) with overlapping behavioural symptoms was analysed. ACE-III scores and behavioural profiles were examined, and novel ratios were tested.

Results: The novel Phonemic Fluency/Orientation-Memory (PFOM) ratio outperformed existing ACE-III metrics, achieving an area under the curve (AUC) of 0.85 (sensitivity 84.1%, specificity 73.1%) for differentiating FTLD from AD. Notably, longer symptom duration in AD, but not in FTLD, was associated with worsening frontal and cognitive symptoms. Patients with AD were significantly older than those with FTLD.

Discussion: These novel ratios showed robust diagnostic performance, regardless of disease duration, and better reflects FTLD's cognitive profile. It may offer improved clinical utility over traditional ACE-III measures.
DOI: 10.6084/m9.figshare.31422272.v1
title: Supplementary Material for: Differentiating behavioural presentations of biomarker-confirmed Alzheimer’s disease from frontotemporal lobar degeneration using the Addenbrooke's Cognitive Examination-III

description: Introduction: Differentiating frontotemporal lobar degeneration (FTLD) from Alzheimer’s disease (AD), particularly when presenting with overlapping behavioural symptoms, remains clinically challenging. This study assessed the utility of Addenbrooke's Cognitive Examination-III (ACE-III)-derived ratios in distinguishing these conditions.

Methods: A retrospective cohort of 115 patients (n=52 biomarker-confirmed AD, n=63 FTLD) with overlapping behavioural symptoms was analysed. ACE-III scores and behavioural profiles were examined, and novel ratios were tested.

Results: The novel Phonemic Fluency/Orientation-Memory (PFOM) ratio outperformed existing ACE-III metrics, achieving an area under the curve (AUC) of 0.85 (sensitivity 84.1%, specificity 73.1%) for differentiating FTLD from AD. Notably, longer symptom duration in AD, but not in FTLD, was associated with worsening frontal and cognitive symptoms. Patients with AD were significantly older than those with FTLD.

Discussion: These novel ratios showed robust diagnostic performance, regardless of disease duration, and better reflects FTLD's cognitive profile. It may offer improved clinical utility over traditional ACE-III measures.
DOI: 10.13018/bmr19500
title: HuR RRM3 S318D mutant
DOI: 10.13018/bmr19501
title: A novel 4/7-conotoxin LvIA from Conus lividus that selectively blocks 32 vs. 6/323 nicotinic acetylcholine receptors
DOI: 10.13018/bmr19502
title: Protein structure
DOI: 10.13018/bmr19503
title: Circular Permutant of the WW Domain with Loop 1 Excised
DOI: 10.6084/m9.figshare.31422275
title: Supplementary Material for: Impact of Sodium Butyrate Supplementation on Insulin Resistance and Adipose Tissue Modulation in Murine Models of Polycystic Ovary Syndrome

description: Objectives: Polycystic ovary syndrome (PCOS) is an endocrine-metabolic disorder affecting up to 10% of women of reproductive age, commonly associated with visceral obesity, insulin resistance, and chronic low-grade inflammation. Sodium butyrate, a microbial-derived short-chain fatty acid, has been proposed as a therapeutic agent due to its anti-inflammatory and metabolic regulatory properties. However, its efficacy under hyperandrogenic and proinflammatory conditions remains uncertain. Design: Experimental study using female BALB/c mice. Forty animals were allocated into five groups: control (CT), high-fat diet (HFD), dehydroepiandrosterone (DHEA), butyrate without PCOS (BUT), and butyrate with PCOS (DHEA+BUT). Participants/Materials, Setting, Methods: Animals received a high-fat diet (except CT), and hyperandrogenism was induced by DHEA. Sodium butyrate was administered via oral gavage during the last 40 days of the protocol. Body weight, glucose tolerance, adipose tissue mass and morphology, serum adipokines, inflammatory gene expression, and gut microbiota profiles were assessed. Results: Butyrate-treated groups, particularly DHEA+BUT, exhibited greater body weight gain and significant expansion of subcutaneous, visceral, and brown adipose depots (p &lt; 0.01). Adipose morphometry showed reduced adipocyte number with preserved diameter, indicative of hypertrophy, accompanied by elevated IL-6 and TNF-α expression in visceral fat (p &lt; 0.01). Leptin levels tended to increase, while adiponectin was significantly reduced in the DHEA+BUT group. Glucose tolerance was impaired in all high-fat diet groups, with the BUT group showing the highest glycemic peaks. Although butyrate increased gut microbial diversity, it failed to prevent metabolic or inflammatory dysfunction. Limitations: The modest number of animals per group reduced statistical power, reflecting constraints in breeding and availability of age-matched BALB/c mice. Their relatively small adipose depots limited tissue yield for molecular and histological assays. Daily oral gavage, required for precise dosing, was technically challenging and led to the loss of one DHEA+BUT animal. Microbiota sequencing was performed in only one animal per group due to high costs, limiting the strength of conclusions regarding microbial changes. Finally, lean mass composition was not directly assessed, although depot weights strongly support adipose expansion. Conclusions: In this model of pre-established obesity and hyperandrogenism, butyrate supplementation was not metabolically protective. Instead, it was associated with worsened adipose inflammation, altered adipokine profiles, and impaired glucose regulation. These findings highlight the context-dependent nature of butyrate’s effects and caution against its generalization as a universally beneficial metabolic modulator.
DOI: 10.6084/m9.figshare.31422275.v1
title: Supplementary Material for: Impact of Sodium Butyrate Supplementation on Insulin Resistance and Adipose Tissue Modulation in Murine Models of Polycystic Ovary Syndrome

description: Objectives: Polycystic ovary syndrome (PCOS) is an endocrine-metabolic disorder affecting up to 10% of women of reproductive age, commonly associated with visceral obesity, insulin resistance, and chronic low-grade inflammation. Sodium butyrate, a microbial-derived short-chain fatty acid, has been proposed as a therapeutic agent due to its anti-inflammatory and metabolic regulatory properties. However, its efficacy under hyperandrogenic and proinflammatory conditions remains uncertain. Design: Experimental study using female BALB/c mice. Forty animals were allocated into five groups: control (CT), high-fat diet (HFD), dehydroepiandrosterone (DHEA), butyrate without PCOS (BUT), and butyrate with PCOS (DHEA+BUT). Participants/Materials, Setting, Methods: Animals received a high-fat diet (except CT), and hyperandrogenism was induced by DHEA. Sodium butyrate was administered via oral gavage during the last 40 days of the protocol. Body weight, glucose tolerance, adipose tissue mass and morphology, serum adipokines, inflammatory gene expression, and gut microbiota profiles were assessed. Results: Butyrate-treated groups, particularly DHEA+BUT, exhibited greater body weight gain and significant expansion of subcutaneous, visceral, and brown adipose depots (p &lt; 0.01). Adipose morphometry showed reduced adipocyte number with preserved diameter, indicative of hypertrophy, accompanied by elevated IL-6 and TNF-α expression in visceral fat (p &lt; 0.01). Leptin levels tended to increase, while adiponectin was significantly reduced in the DHEA+BUT group. Glucose tolerance was impaired in all high-fat diet groups, with the BUT group showing the highest glycemic peaks. Although butyrate increased gut microbial diversity, it failed to prevent metabolic or inflammatory dysfunction. Limitations: The modest number of animals per group reduced statistical power, reflecting constraints in breeding and availability of age-matched BALB/c mice. Their relatively small adipose depots limited tissue yield for molecular and histological assays. Daily oral gavage, required for precise dosing, was technically challenging and led to the loss of one DHEA+BUT animal. Microbiota sequencing was performed in only one animal per group due to high costs, limiting the strength of conclusions regarding microbial changes. Finally, lean mass composition was not directly assessed, although depot weights strongly support adipose expansion. Conclusions: In this model of pre-established obesity and hyperandrogenism, butyrate supplementation was not metabolically protective. Instead, it was associated with worsened adipose inflammation, altered adipokine profiles, and impaired glucose regulation. These findings highlight the context-dependent nature of butyrate’s effects and caution against its generalization as a universally beneficial metabolic modulator.
DOI: 10.13018/bmr19504
title: baa38
DOI: 10.13018/bmr19505
title: WW Domain Strand-Swapped Dimer
DOI: 10.13018/bmr19506
title: Human eukaryotic release factor eRF1
DOI: 10.13018/bmr19507
title: Backbone assignment and Secondary Structure of Intrinsically Unstructured Culture Filtrate Antigen protein (CFP10) from Mycobacterium Tuberculosis
DOI: 10.13018/bmr19508
title: Solution structure of the human wild type FAPP1-PH domain
DOI: 10.13018/bmr19510
title: NMR structure of the Paracoccus denitrificans Z-subunit determined in the presence of ADP
DOI: 10.13018/bmr19511
title: NMR Structure of the homeodomain transcription factor Gbx1 from Homo sapiens solved in the presence of the DNA sequence CGACTAATTAGTCG
DOI: 10.13018/bmr19512
title: HIV-1 gp41 clade B double alanine mutant Membrane Proximal External Region peptide in DPC micelle
DOI: 10.13018/bmr19513
title: HIV-1 gp41 clade C Membrane Proximal External Region peptide in DPC micelle
DOI: 10.13018/bmr19514
title: HIV-1 gp41 clade C Membrane Proximal External Region peptide in DPC micelle
DOI: 10.13018/bmr19515
title: HIV-1 gp41 clade C Membrane Proximal External Region peptide in DPC micelle
DOI: 10.13018/bmr19516
title: Solution NMR structure of Dot1L in complex with AF9 (Dot1L-AF9).
DOI: 10.13018/bmr19517
title: Micelle-solubilized transmembrane domain of the hepatitis C virus glycoprotein E1
DOI: 10.13018/bmr19518
title: Solution NMR assignment of the heavy chain complex of the human cardiac myosin regulatory light chain
DOI: 10.13018/bmr19519
title: NMR solution structure of the GS-TAMAPIN MUTATION R6A.
DOI: 10.13018/bmr19520
title: Solution Structure of BCL-xL in its p53-bound conformation determined with selective isotope labelling of I,L,V sidechains
DOI: 10.13018/bmr19521
title: Solution structure of BCL-xL containing the alpha1-alpha2 disordered loop determined with selective isotope labelling of I,L,V sidechains
DOI: 10.13018/bmr19522
title: Solution Structure of the Complex Between BCL-xL and the p53 Core Domain determined with PRE restraints
DOI: 10.13018/bmr19523
title: N-terminal domain of Bilbo1 from Trypanosoma brucei
DOI: 10.13018/bmr19524
title: NMR solution structure of the GS-TAMAPIN MUTATION R7A.
DOI: 10.13018/bmr19525
title: Solution structure of the Nt. GR-RBP1 RRM domain
DOI: 10.13018/bmr19526
title: Solution NMR structure of SLED domain of Scml2
DOI: 10.13018/bmr19527
title: NMR solution structure of the GS-TAMAPIN MUTATION R13A.
DOI: 10.13018/bmr19528
title: NMR solution structure of the DOUBLE GS-TAMAPIN MUTATION R6A R7A.
DOI: 10.13018/bmr19530
title: Resonance assignment of RQC domain of human Bloom syndrome protein
DOI: 10.13018/bmr19531
title: NMR spatial structure of the trimeric mutant TM domain of VEGFR2 receptor.
DOI: 10.13018/bmr19532
title: NMR spatial structure of mutant dimeric TM domain of VEGFR2 receptor
DOI: 10.13018/bmr19533
title: Solution Structure of NusE (S10) from Thermotoga maritima
DOI: 10.13018/bmr19534
title: Structural basis of the non-coding RNA RsmZ acting as protein sponge: Conformer L of RsmZ(1-72)/RsmE(dimer) 1to3 complex
DOI: 10.13018/bmr19535
title: SGTX-Sf1a
DOI: 10.13018/bmr19536
title: 1H, 13C, 15N chemical shift assignments of Streptomyces virginiae VirA acp5a
DOI: 10.13018/bmr19538
title: SOLUTION STRUCTURE OF THE IMS DOMAIN OF THE MITOCHONDRIAL IMPORT PROTEIN TIM21 FROM S. CEREVISIAE